Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Changes

12 Mar 2021 09:00

RNS Number : 9998R
Sainsbury(J) PLC
12 March 2021
 

12 March 2021

J Sainsbury plc - Directorate Changes

Appointment of Adrian Hennah as Non-Executive Director and Chair of Audit Committee

J Sainsbury plc today announces that Adrian Hennah will join the Board as a Non-Executive Director. Adrian will join the Audit Committee and Nomination Committee on 1 April 2021 and will take over as Chair of the Audit Committee following the AGM.

Adrian will replace David Keens, who is not seeking re-election to the Board at the July 2021 AGM after six years of service.

Commenting on the appointment, Martin Scicluna, Chairman of Sainsbury's, said:

"I am delighted to welcome Adrian as a Non-Executive Director and Chair of the Audit Committee. As a highly accomplished CFO of three FTSE100 companies spanning 18 years, he has significant and varied expertise. Additionally, Adrian was a Non-Executive Director and Audit Committee Chair of another FTSE100 company for nine years and I am confident he will bring fresh thinking to our Board as we deliver against our plan.

"I would like to thank David Keens for his six years of service. He has been a thoughtful and influential voice on the Board and we are grateful for his significant contribution."

Adrian Hennah said:

"I am very pleased to be joining Sainsbury's and look forward to bringing my experience to the Board. I am familiar with the business through previous roles and have always been impressed by the company's values and commitment to do the right thing for its customers. It is an exciting time to be involved in food retail and I am looking forward to getting started."

Adrian spent 18 years in Chief Financial Officer (CFO) roles at three FTSE 100 companies. He was CFO at RB for seven years and held the same position at Smith & Nephew and Invensys. Prior to this he spent 18 years at GSK working in both finance and operations. Adrian began his career at PWC.

Adrian was previously Non-Executive Director and Chair of the Audit Committee at RELX. He stepped down from the Board last year having completed nine years of service. No further information is required to be disclosed under 9.6.13R of the UK Listing Rules.

 

Ends

Enquiries:

Investor Relations Media Relations

James Collins +44 (0) 20 7695 0080 Rebecca Reilly +44 (0) 20 7695 7295

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFFFXLEBBF
Date   Source Headline
2nd Jun 20263:04 pmRNSAnnual Report and Notice of AGM 2026
1st Jun 20262:00 pmRNSDirector/PDMR Shareholding
1st Jun 20261:00 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
8th May 20263:30 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20262:30 pmRNSDirector/PDMR Shareholding
1st May 20261:00 pmRNSTotal Voting Rights
1st May 202610:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20263:15 pmRNSDirector/PDMR Shareholding
27th Apr 20262:00 pmRNSPresentation via Investor Meet Company
24th Apr 20264:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSCommencement of Share Buyback Programme
23rd Apr 20267:00 amRNSPreliminary Results
10th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 20263:50 pmRNSTotal Voting Rights
1st Apr 20262:30 pmRNSHolding(s) in Company
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
10th Mar 20263:30 pmRNSHolding(s) in Company
10th Mar 20263:30 pmRNSHolding(s) in Company
5th Mar 20263:00 pmRNSAdditional Listing
2nd Mar 20261:00 pmRNSTotal Voting Rights
13th Feb 20263:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:20 pmRNSTotal Voting Rights
23rd Jan 20262:15 pmRNSEMTN Programme Publication of Base Prospectus
20th Jan 20267:00 amRNSTransaction in Own Shares and Programme Completion
19th Jan 20263:25 pmRNSBlock listing Interim Review
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20262:30 pmRNSDirector/PDMR Shareholding
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20262:00 pmRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:05 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTrading Statement
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20262:04 pmRNSTransaction in Own Shares - Replacement
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20263:30 pmRNSHolding(s) in Company
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20261:00 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20251:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.